| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
Acetamide, N-[4-[3-[(4-chlorophenyl)methylene]-2,3-dihydro-2-oxo-5-phenyl-1H-pyrrol-1-yl]phenyl]- manufacturers
- inS3-54-A26
-
- $70.00
-
2026-08-08
- CAS:328998-77-2
- Purity: 99.57%
- Supply Ability: 10g
|
| | Acetamide, N-[4-[3-[(4-chlorophenyl)methylene]-2,3-dihydro-2-oxo-5-phenyl-1H-pyrrol-1-yl]phenyl]- Basic information |
| | Acetamide, N-[4-[3-[(4-chlorophenyl)methylene]-2,3-dihydro-2-oxo-5-phenyl-1H-pyrrol-1-yl]phenyl]- Chemical Properties |
| Boiling point | 700.7±60.0 °C(Predicted) | | density | 1.343±0.06 g/cm3(Predicted) | | pka | 14.56±0.70(Predicted) |
| | Acetamide, N-[4-[3-[(4-chlorophenyl)methylene]-2,3-dihydro-2-oxo-5-phenyl-1H-pyrrol-1-yl]phenyl]- Usage And Synthesis |
| Description | inS3-54-A26 is a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppressing tumor growth, metastasis and STAT3 target gene expression in vivo. | | Uses | inS3-54-A26 is a STAT3 inhibitor. inS3-54-A26 has a toxic IC50 of 4.0 μM for non-cancerous lung fibroblasts[1]. | | References | [1] Huang W, et al. Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo. Oncogene. 2016 Feb 11;35(6):783-92. DOI:10.1038/onc.2015.215 |
| | Acetamide, N-[4-[3-[(4-chlorophenyl)methylene]-2,3-dihydro-2-oxo-5-phenyl-1H-pyrrol-1-yl]phenyl]- Preparation Products And Raw materials |
|